Verona Submits New Drug Application for Ensifentrine for COPD
If approved, it is expected to be the first novel mechanism available for the treatment of COPD in over 10 years.
Tag: Verona Pharma
Verona Submits New Drug Application for Ensifentrine for COPD
If approved, it is expected to be the first novel mechanism available for the treatment of COPD in over 10 years.
Read More
COPD: Nebulized Ensifentrine Improved Lung Function, Reduced Exacerbations
A phase 3 clinical trial revealed that treatment with nebulized ensifentrine led to significant improvements in lung function, symptoms and quality of life measures in COPD patients.
Read More